Table 3.
Characteristics of Recipients of Transplants from HLA-Incompatible Live Donors as Compared with Matched Controls.*
| Characteristic | Recipients of Transplants from Incompatible Live Donors (N = 1025) | Waiting-List-or-Transplant Control Group (N = 5125) | Waiting-List-Only Control Group (N = 5125) |
|---|---|---|---|
| Age at transplantation — yr† | 45.0±12.8 | 45.9±12.1 | 46.6±12.0 |
| Female sex — no. (%) | 687 (67.0) | 3444 (67.2) | 3452 (67.4) |
| Black race — no. (%)‡ | 168 (16.4) | 844 (16.5) | 840 (16.4) |
| No. of previous kidney transplants — no. of patients (%)§ | |||
| 0 | 612 (59.7) | 3323 (64.8) | 3321 (64.8) |
| 1 | 350 (34.1) | 1584 (30.9) | 1552 (30.3) |
| 2 | 57 (5.6) | 202 (3.9) | 231 (4.5) |
| ≥3 | 6 (0.6) | 16 (0.3) | 21 (0.4) |
| Median panel-reactive antibody (IQR) — % | 66 (22–94) | 68 (20–95) | 68 (21–95) |
| Diabetes mellitus — no. (%) | 210 (20.5) | 1047 (20.4) | 1047 (20.4) |
| Duration of renal-replacement therapy — yr | 7.3±7.6 | 7.3±7.4 | 7.4±7.4 |
*
Plus–minus values are means ±SD. There were no significant between-group differences in baseline characteristics except as noted.
†
P = 0.02 for the comparison between patients who received transplants from incompatible live donors and patients in the waiting-list-only control group.
‡
Race was determined by staff at the transplant centers.
§
P = 0.004 for the comparison between patients who received transplants from incompatible live donors and patients in the waiting-list-or-transplant control group.